Self Care, Skin Health and Beauty, and Essential Health. Self Care product categories include pain care; cough cold allergy; ...

周四，Jefferies重申了对Kenvue Inc (NYSE:KVUE)的买入评级，目标价维持在$27.00。该公司的展望基于对公司护肤板块的转机预期，预计该板块将在2026年前反弹。分析强调，大规模的品牌改造通常需要时间才能见效。

By Svea Herbst-Bayliss (Reuters) -Hedge fund Starboard Value called consumer products company Kenvue a bargain and said its ...

The growth rate of the consumer healthcare business could accelerate now that an activist investor is involved.

知情人士透露，对冲基金Starboard Value已入股消费品公司Kenvue，后者于去年上市，前身为强生公司消费者健康业务，公司旗下品牌包括露得清、邦迪、泰诺等。Kenvue的代表尚未就此发表评论。（路透） ...

格隆汇10月21日｜据路透援引两位知情人士称，对冲基金 Starboard ...

(Reuters) -Hedge fund Starboard Value has taken a stake in Kenvue, the consumer products company that makes Band-Aid, ...

So part of the recent run-up is simply due to investors resetting expectations. However, Kenvue stock jumped 5.5% on Oct. 21 ...

纽约 - 以参与上市公司著称的投资公司Starboard Value LP最近在2024年主动-被动投资者峰会上介绍了其提升股东价值的策略。该公司首席执行官兼首席投资官Jeffrey Smith展示了Kenvue Inc. (NYSE: ...

Financial writer reports activist investor Starboard Value's stake in Kenvue Inc., seeking measures to boost stock price.

Kenvue是一家美国保健品销售商，前身为强生公司消费者健康业务，公司旗下品牌包括泰诺、露得清、李斯德林、约翰逊、邦迪创可贴、Aveeno、Zyrtec和nicorette等个人护理产品。对冲基金Starboard Value日前入股Kenvue，希望Kenvue实施变革来提振股价。

强生(JNJ.US)去年8月分拆上市的消费者产品公司Kenvue(KVUE.US)於美股盘前股价上扬约7%，多间外国传媒引述消息人士称，维权对冲基金Starboard Value买入 ...